Influx Healthtech IPO

About the company

Incorporated in 2020, Influx Healthtech Limited is a healthcare-focused contract development and manufacturing organisation (CDMO). The company specialise in manufacturing various nutraceutical, cosmetics, ayurvedic/herbal products, veterinary feed supplements, and other medical products. The company has a manufacturing unit in Thane, Maharashtra, with an installed capacity of 10,000 kg for nutraceutical products as of FY25 and a capacity utilisation of 93%. In FY25, the company served 571 clients, with 93.7% of total revenue coming from existing customers and the rest from new clients. Meanwhile, the nutraceuticals products category, under which the company offers 3018 products, contributed 89.6% to overall revenue in FY25.

Financial performance (₹ Cr)

Subscription breakup (final, times)

IPO Roadmap / Timeline

1. IPO Opens

   Completed
   18 Jun 2025

   Bidding starts for all investor categories

2. IPO Closes

   Completed
   20 Jun 2025

   Last day to place your bid

3. Basis of Allotment

   Completed
   23 Jun 2025

   Share allotment finalised

4. Refund Initiation

   Completed
   24 Jun 2025

   Refunds credited for non-allottees

5. Credit to Demat

   Completed
   24 Jun 2025

   Allotted shares credited to demat account

6. Listing on Exchange

   Completed
   25 Jun 2025

   Shares list on NSE / BSE

Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.